Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in number of shares and votes in Alligator Bioscience AB (publ)

Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that the number of shares and votes in Alligator Bioscience AB (publ) has increased due to that 575,000 warrants in the warrant program 2014/2017 issued pursuant to the resolution by the extraordinary shareholders’ meeting on 5 November 2013 have been excercised for subscription of 575,000 new shares. As of March 31, 2017, the number of shares and votes in Alligator Bioscience AB amounts to 71,388,615About AlligatorAlligator is a biotechnology company that develops innovative immune activating antibody drugs

Notice of Ahlsell AB’s Annual General Meeting on May 4, 2017

The shareholders of Ahlsell AB (publ) ("Ahlsell") are hereby invited to the Annual General Meeting on Thursday 4 May 2017 at 4.00 p.m. CET at Musikaliska, Nybrokajen 11 in Stockholm, Sweden. Entry to the Annual General Meeting will commence at 3.00 p.m. CET.PARTICIPATION Shareholders who wish to attend the Annual General Meeting shall       be entered in the share register maintained by Euroclear Sweden AB on Thursday 27 April 2017, shall       give notice of their attendance to Ahlsell no later than Thursday 27 April 2017. Notification shall be made on the company’s website www.

Notice of the Annual General Meeting of Fastighets AB Balder (publ)

Shareholders of Fastighets AB Balder (publ), corporate identity no. 556525-6905, are hereby notified of the Annual General Meeting (AGM) to be held on Thursday, May 11, 2017 at 16.00, local time, at Radisson Blu Scandinavia Hotel, Södra Hamngatan 59, Gothenburg, Sweden.Right to participate in the Annual General Meeting Shareholders wishing to participate in the AGM shall be listed as shareholders (not trustee-registered) in the share register held by Euroclear Sweden AB as of Friday, May 5, 2017, and have notified of their intention to attend by no later than 16.00, local time, on

Canadian Broadcasting Corporation signs agreement with Cxense

Oslo, Norway – 31 March 2017 – Cxense ASA (OSE: CXENSE) today announced that Canadian Broadcasting Corporation (CBC/Radio-Canada) has signed an agreement with Cxense for use of data management and personalization software.   CBC/Radio-Canada provides content across various channels including radio, television, digital media and mobile. The company has since it was established in 1936 been a key source of news, information and entertainment for the Canadian people, a position which today is reflected in it being one of the strongest media brands in the country. CBC/Radio-Canada will

Idogen recruits Chief Medical Officer

Idogen AB (”Idogen”) announces that it has recruited Dr. Steven Glazer to the position of Chief Medical Officer (CMO) commencing the 1st of April. This appointment means a significant strengthening of the organization for future clinical studies, initially in hemophilia A. Steven Glazer’s most recent role was as CMO at Hansa Medical AB, listed on Nasdaq Stockholm.Steven Glazer has an extensive experience from senior positions in clinical drug development. His previous assignments include Senior Vice President of Development at BioInvent AB, Vice President of Development at Zealand Pharma

LKAB publishes its 2016 Annual and Sustainability Report

LKAB announces that its 2016 Annual and Sustainability Report has been published and is available in Swedish at lkab.comA summary in English, Annual and Sustainability Report in brief, is available at www.lkab.com/annual-and-sustainability-reports/. The full version of the Annual and Sustainability Report 2016 will be published in English at the end of April.A printed copy of the Annual Report in Swedish will be available at the AGM in Luleå on the 27th of April and can also be ordered by e-mail to info@lkab.com. A printed copy of the Annual Report in English will be available in the

Number of shares and votes in Medivir

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the number of shares and votes in Medivir has changed as a result of redemption of share under the voluntary redemption programme resolved at the extraordinary general meeting on 2 February 2017. The new number of shares has been registered with the Swedish Companies Registration Office during March 2017. Today, the last trading day of the month, the total number of outstanding shares in Medivir are 20,318,977, whereof 474,769 series A shares and 19,844,208 series B shares, and the total number of votes amounts

Probi publishes annual report for 2016

This information was submitted for disclosure on 31 March 2017 at 08.30 (cet).Probi's Annual Report for 2016 is now available on the company website, www.probi.com under Investors / Financial Reports / Annual Reports. Distribution of the printed annual report will start during week 15 to shareholders who subscribe to our financial reporting. This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 8.30 CET on 31 March 2017. FOR FURTHER INFORMATION, CONTACT:Peter Nählstedt, CEO,

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 25 000 treasury shares on 30 March 2017. The shares were purchased at an average price of NOK 37.90. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 1 257 990 treasury shares. Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at

Q-FREE- ANNUAL ACCOUNTS 2016

Trondheim 31 March 2017: The Board of Directors of Q-Free ASA has on 30 March 2017 approved the Directors Report and the Consolidated Financial Statements for 2016. The Consolidated Financial Statements are presented according to IFRS and will be presented for final approval at the Annual General Meeting scheduled to be held 24 May 2017. The Group's Annual Audited Consolidated Financial Statements include no changes compared to the preliminary full year results presented 14 February 2017.The Board of Directors proposes to the Annual General Meeting that there will be no distribution of

Badger Explorer ASA - Increase Of The Company's Share Capital

Reference is made to previous announcements published by Badger Explorer ASA (the "Company") regarding the Subsequent Offering II. The share capital increase pertaining to the new shares issued in the Subsequent Offering II has now been registered with the Norwegian Register of Business Enterprises. The Company's share capital has consequently been increased with NOK 7,591,893.75 to NOK 139,909,054.75. The Company's new registered share capital is NOK 139,909,054.75 divided into 1,119,272,438 shares, each with a nominal value of NOK 0.125. The new shares will be delivered to the

Launch of new sensor surfaces for Insplorion’s instruments

Today Insplorion introduces two new sensor surfaces for their instrument family. A completely flat sensor, with embedded nanoparticles, for the Acoulyte instrument and a sensor with larger caves that, for example, can be used to study the transport of drug candidates across cell membranes. The new additions to Insplorion’s sensor family, open up for new application areas and new customer groups that can use Insplorion's measuring instruments.The new flat Acoulyte sensors facilitate for users of the QCM-D instrument to compare their previous results, obtained using flat QCM sensors, with

Key information relating to cash dividend to be paid by Atea ASA

The Board of Atea ASA has proposed a cash dividend with the following key details:  Dividend amount:                           3.25 per shareDeclared currency:                         NOKLast day including right:                  27.04.2017Ex-date:                                          28.04.2017Record date:                                   02.05.2017Payment date:                                12.05.2017Date of approval:                            27.04.2017  For Norwegian tax purposes, the dividend shall be considered as repayment of paid in capital.This

Interim Report Nepa AB (publ)

Record sales growth in fourth quarter.This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version governs. FOURTH QUARTER, OCTOBER – DECEMBER 2016 · Net sales increased by 25.3% to MSEK 55.2 (44.0) · Gross profit increased by 14.8% to MSEK 40.3 (35.1) · EBIT amounted to MSEK 0.4 (2.8) · Earnings after tax amounted to MSEK 0.6 (3.1) · Earnings per share amounted to SEK 0.07 (2.70) FULL YEAR, JANUARY – DECEMBER 2016 · Net sales increased by 19.4% to MSEK 184.4 (154.5) · Gross profit increased by 16.6%

The Nasdaq Helsinki Disciplinary Committee issues Digia Plc with a warning and fine for violating the rules of the Exchange

Digia PlcStock exchange release31 March 2017 at 9:05 am The Nasdaq Helsinki Disciplinary Committee issues Digia Plc with a warning and fine for violating the rules of the Exchange The Nasdaq Helsinki Disciplinary Committee has issued Digia Plc with a warning and a fine of EUR 40,000 for violating the rules of the Exchange. The decision relates to the Finnish Tax Administration's selection of a solution supplier for the national income register and the communication of this issue. According to the decision, Digia Plc breached the sections of the Exchange's rules relating to

Tagrisso (osimertinib) receives FDA full approval

31 March 2017 07:00 BST TAGRISSO (OSIMERTINIB) RECEIVES US FDA FULL APPROVAL  Conversion from accelerated to full approval confirms the potential of Tagrisso to become standard of care in the US Approval based on Phase III AURA3 trial that demonstrated significant improvement in progression-free survival with Tagrisso as compared to chemotherapy AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic epidermal growth factor receptor (EGFR)

DDM Treasury Sweden AB publishes its 2016 Annual report

DDM Treasury Sweden AB today published its 2016 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch.A printed copy can be ordered via the website or by phone: +46 8 4080 9030. The audit report deviates from the standard due to late payment of taxes in 2016. This is information which DDM Treasury Sweden AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08:00 CET on 31 March 2017.

Tomas Björksiöö leaves his position as CFO at Attendo

Attendo’s Chief Financial Officer (CFO) Tomas Björksiöö has decided to leave Attendo after 16 years in the company.“Tomas has had a number of roles in Attendo as controller, as financial manager in one of the business areas, and, for the last ten years, as CFO. Tomas has played a vital role in building up and developing Attendo during several years. Tomas also had a leading role in the successful IPO of Attendo in 2015. I want to thank Tomas for his excellent work and wish him the best of luck in his new endeavors”, says Henrik Borelius, CEO of Attendo.The process to appoint a new CFO has

New number of votes in Bonava AB due to conversion

The number of shares and votes in Bonava AB has changed due to conversions of a total of 18,616 shares of series A to a total of 18,616 shares of series B.According to Bonava’s articles of association, owner of a share of series A has the right to request that such share is converted to a share of series B. In February, 18,616 shares of series A shares were converted to 18,616 shares of series B at the request of shareholders. Following the conversions, there were, as of February 28, the last trading day of the month, a total of 108,435,822 registered shares in Bonava AB. Of these 13,451,

Catena Media secures long term cooperation with SBAT founder Gary Gillis

Catena Media and Gary Gillis have mutually agreed to amend the terms and conditions of their previous agreement to provide the best long term value for both parties. The former earn-out agreement will be replaced by an immediate payment of EUR 3,254,000 where EUR 2,000,000 to be invested in Catena Media shares.Gary Gillis will be fully employed by Catena Media and will thereby be part of the long-term development of the company. Gary Gillis will have a lock-up period of two years on the shares he commits to purchase according to the new  agreement. Catena Media acquired UK-based SBAT, a

New number of votes in Addnode Group

The number of shares and votes in Addnode Group AB (publ) has changed due to the conversion of 66 073 A shares to 66 073 B shares.According to Addnode Group's articles of association, owners of Class A shares are entitled to request that the shares be converted into B shares. In March, at the request of shareholders, 66,073 A shares were converted into 66,073 B shares. After the conversion, there were, as of March 31, 2017, the last trading day of the month, a total of 30,427,256 registered shares in Addnode Group AB. Of these, 987 174 A shares and 29,440,082 B shares. The number of votes

There are no items matching the current filter
There are no more items matching the current filter
Back to top